Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).

Publication

Citation: Bourdet DL, Pritchard JB, Thakker DR.: Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). J Pharmacol Exp Ther, Volume 315 (3), 2005
Authors: Bourdet DL, Pritchard JB, Thakker DR.
Journal: J Pharmacol Exp Ther
Year: 2005
DOI: 10.1124/jpet.105.091223
PubMed: 16141367
Machine-readable: REST API RDF